Response to Letter to the Editor From Green and Gosmanov: "Tall Cell Percentage Alone in PTC Without Aggressive Features Should not Guide Patients' Clinical Management"

J Clin Endocrinol Metab. 2022 May 17;107(6):e2653-e2654. doi: 10.1210/clinem/dgac055.

Authors

David Viola¹, Anello Marcello Poma², Rossella Elisei¹, Fulvio Basolo²

Affiliations

¹ Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
² Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Italy.

No abstract available

Keywords: papillary thyroid carcinoma; prognosis; recurrence-free survival; tall cells.

Publication types

Letter
Comment

MeSH terms

Carcinoma, Papillary*
Humans
Thyroid Cancer, Papillary
Thyroid Neoplasms*